NASAL POLYPS TREATMENT MARKET ANALYSIS

Nasal Polyps Treatment Market, by Drug Class, (Corticosteroids, (Nasal corticosteroids, Fluticasone, Budesonide, Mometasone, Triamcinolone, Others - Beclomethasone, Ciclesonide, etc.), Oral/Injectable Corticosteroids (Prednisone, Combination), Antibiotics, Antihistamines, Interleukin Inhibitors, (Dupilumab, Others (IL 10, IL 25 etc.)), Monoclonal Antibodies, (Mepolizumab, Omalizumab, Others), Others (Aspirin, anticholinergic agent and etc.)), by Route of Administration (Nasal, Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2022
Code : CMI2775
Pages :520
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players are engaged in receiving approvals for their new drugs from regulatory authorities, which is expected to drive growth of the global nasal polyps treatment market over the forecast period.

Product approvals by regulatory bodies are expected to drive growth of the global nasal polyps treatment market over the forecast period. For instance, on December 1, 2020, Novartis, a pharmaceutical company, had announced that the U.S. Food and Drug Administration had approved its product Xolair (omalizumab). Xolair is used for the treatment of nasal polyps in adult patients. Xolair is the first biologic for the treatment of nasal polyps that aims and blocks immunoglobulin E (IgE).

Global Nasal Polyps Treatment Market – Competitive Landscape

Major players operating in the global nasal polyps treatment market include Regeneron Pharmaceuticals, Inc., Hoffmann-La Roche Ag, Fougera Pharmaceuticals Inc., Novartis International Ag, Sanofi S.A., GlaxoSmithKline Plc, Intersect Ent, Dohme Corp, Merck & Co., Inc., Sanofi S.A., Norton Waterford Ltd, Astrazeneca Plc, Taro Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Limited, and OptiNose Inc.

Nasal Polyps Treatment Market Report Snapshots